대한한의학방제학회지 (Herbal Formula Science)

  • 제25권3호
  • /
  • Pages.429-436
  • /
  • 2017
  • /
  • 1229-1218(pISSN)
  • /
  • 2288-5641(eISSN)
대한한의학방제학회 (The Korean Medicine Society for the Herbal Formula Study)
권호 표지
DOI QR코드

DOI QR Code

치자벽피탕(梔子檗皮湯)으로 호전을 보인 아토피피부염의 치험 2례

Two cases of Atopic Dermatitis Treated with Chijabyukpi-tang

  • 박승구 (원광대학교 한의과대학 한방안이비인후피부과) ;
  • 노현민 (원광대학교 한의과대학 한방안이비인후피부과) ;
  • 조은희 (원광대학교 한의과대학 침구과) ;
  • 박민철 (원광대학교 한의과대학 한방안이비인후피부과)
  • Park, Sung-gu (Dept. of Korean Medical Ophthalmology, Otolaryngology & Dermatology, Wonkwang University) ;
  • Noh, Hyeon-Min (Dept. of Korean Medical Ophthalmology, Otolaryngology & Dermatology, Wonkwang University) ;
  • Jo, Eun-Hee (Dept. of Acupunture and Moxibustion, Wonkwang University) ;
  • Park, Min-Cheol (Dept. of Korean Medical Ophthalmology, Otolaryngology & Dermatology, Wonkwang University)
  • 투고 : 2017.08.16
  • 심사 : 2017.08.25
  • 발행 : 2017.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : This case report presents the effect of Chijabyukpi-tang(梔子檗皮湯) on Atopic Dermatitis. The patient was diagnosed with Yangmyung-Yeoljeung(陽明熱證) based on Shanghanlun provisions. Methods : We have classified the patients according to the shanghanlun six meridian patterns diagnostic system and the patients are treated with Chijabyukpi-tang. The severity of Atopic dermatitis was evaluated by SCORAD index, visual analouge scale(VAS) and pictures. Results : After the treatment, the SCORAD index of 2 patients decreased from 78 to 20.2 and from 67.4 to 38.2 respectively. Conclusions : Although Chijabyukpi-tang is unusual treatment for Atopic dermatitis, this case report showed the effectiveness of using Chijabyukpi-tang on Atopic dermatitis according to shanghanlun six meridian patterns diagnostic system.

키워드

참고문헌

  1. Hong SJ. Korean ISAAC study Group of Korean Association of Allergy and Respiratory Diseases: Report of Korean ISAAC epidemiologic study for asthma and allergic diseases in children. Pediatr Allergy Respir Dis. 2007;17:Suppl 1:S55-66.
  2. Evidence Based Korean Medicine Clinical Practice Guideline Development Committee for Atopic Dermatitis (Korea Institute of Oriental Medicine, The Society of Korean Medical Ophthalmology, Otolaryngology, Dermatology). Korean Medicine Clinical Practice Guideline for Atopic dermatitis. Daejeon: Korea. 2015:34.
  3. Evidence Based Korean Medicine Clinical Practice Guideline Development Committee for Atopic Dermatitis (Korea Institute of Oriental Medicine, The Society of Korean Medical Ophthalmology, Otolaryngology, Dermatology). Korean Medicine Clinical Practice Guideline for Atopic dermatitis. Daejeon: Korea. 2015:10-11.
  4. Park SG, Noh HM, Hwang CY, Hong SH, Park MC, et al. Classification of Atopic Dermatitis into Digestive and Respiratory Disorders on the Basis of a Literature Study. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(3):106-23. https://doi.org/10.6114/jkood.2016.29.3.106
  5. Park Y. Status of clinical practice on diagnosis and management of atopic dermatitis in Korea: a questionnaire survey of physicians. Allergy Asthma Respir Dis. 2013;1(3):257-65. https://doi.org/10.4168/aard.2013.1.3.257
  6. Jung JY, Kim YB. Three cases of Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2004;17(1):131-9.
  7. Hong SM, Hur IH, Byun HS, sim SY, Kim KJ. A case study on Atopic dermatitis with the Treatise on Febrile Diseases. J Korean Med Ophthalmol Otolaryngol Dermatol. 2007;20(2):230-9.
  8. Hong SM, Hur IH, Sim SY, Kim KJ. A case of Atopic dermatitis treated with sihogeji-tang. J Korean Med Ophthalmol Otolaryngol Dermatol. 2008;21(3):215-25.
  9. Lee JG, Kim HJ. A clinical case of atopic dermatitis with Gyemagakbantang. Semyung Uni. 2008;11: 15-28.
  10. Yun SM, Im EK. A case report of atopic dermatitis treated by Osuyu-tang(Wuzhuyu-tang) based on shanghanlun provisions. The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2013;5(1):85-92.
  11. Jo SH, Jo EH, Kim SJ, Park IH, Park MC. Two cases of Atopic Dermatitis Treated with Huini-san. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(3):180-90. https://doi.org/10.6114/jkood.2014.27.3.180
  12. Lee SJ, Ryu HC. A case report of atopic dermatitis treated bu gamchosasim-tang based on shanghanlun provisions. The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2014;6(1):71-8.
  13. Min JH, Jo SH. A case report of atopic dermatitis treated by soshiho-tang based on shanghanlun provisions. The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe. 2015;7(1):75-85.
  14. Noh HM, Park SG, Park IH, Jo EH, Park MC. Twe cased of atopic dermatitis with gastrointestinal disorders treated with soshiho-tang. J Korean Med Ophthalmol Otolaryngol Dermatol. 2016;29(3): 208-16. https://doi.org/10.6114/jkood.2016.29.3.208
  15. Lee DH, Doh EJ, Lee JY, Park Y, Oh JW, et al. Multicenter questionnaires on the current management of atopic dermatitis in Korea. Allergy Asthma Respir Dis. 2016;4(4):271-5. https://doi.org/10.4168/aard.2016.4.4.271
  16. Kang HG, Lee SA, Kim HJ, Yum HY. The measurement of serum corticosteroid level in atopic dermatitis patients associated with application of topical corticosteroids. Allergy Asthma Respir Dis. 2017;5(2):79-82. https://doi.org/10.4168/aard.2017.5.2.79
  17. Lee SR, Jeon BH, Woo WH, Jeong WY. Effect of chijabakpitang on the Liver Damage Induced by Bile Duct Ligation. The Journal of Wonkwang Oriental Medicine. 1994;4(1):191-205.
  18. Shigeta Y, Yonemitsu Y, Matsumoto R. Clinical and Experimental Features of Shishihakuhito. Pharmacometrics. 2006;71(3):67-72.
  19. Wakabayashi M, Sakurai E, Yanai K, Umemura K, Yoshida M, et al. Shishihakuhito, a traditional Chinese medicine for atopic dermatitis, inhibits IgE-mediated histamine release from rat RBL-2H3 basophilic leukocyte cells. Journal of Traditional Medicines. 2009;26(1):44-9.
  20. Nakanishi K, Kawahata I, Sun W, Wang Y, Yoshida M, et al. Shishihakuhito, a Kampo medicine for atopic dermatitis, suppresses NGF-induced neurite extension by inhibition of MEK/ERK signaling in PC12D cells. Journal of Traditional Medicines. 2011;28(1):16-21.